Mephenesin

Mephenesin

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	M03BX06 (WHO)
Identifiers
IUPAC name 3-(2-methylphenoxy)propane-1,2-diol
CAS Number	59-47-2 N
PubChem (CID)	4059
ChemSpider	3919 Y
UNII	7B8PIR2954 Y
KEGG	D02595 Y
ChEMBL	CHEMBL229128 Y
NIAID ChemDB	017830
ECHA InfoCard	100.000.389
Chemical and physical data
Formula	C10H14O3
Molar mass	182.216 g/mol
3D model (Jmol)	Interactive image
SMILES O(c1ccccc1C)CC(O)CO
InChI InChI=1S/C10H14O3/c1-8-4-2-3-5-10(8)13-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3 Y Key:JWDYCNIAQWPBHD-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Mephenesin is a centrally acting muscle relaxant. It can be used as an antidote for strychnine poisoning. Mephenesin however presents with the major drawbacks of having a short duration of action and a much greater effect on the spinal cord than the brain, resulting in pronounced respiratory depression at clinical doses and therefore a very low therapeutic index. It is especially dangerous and potentially fatal in combination with alcohol and other depressants.^[1] Mephenesin was used by Dr. Bernard Ludwig and Dr. Frank Milan Berger to synthesize meprobamate, the first tranquilizer to see widespread clinical use. Mephenesin is no longer available in North America but is used in France, Italy and a few other countries.^[2] Its use has largely been replaced by the related drug methocarbamol, which is better absorbed^[3]

Mephenesin may be an NMDA receptor antagonist.^[4]

See also

• Chlorphenesin
• Guaifenesin
• Mephenoxalone
• Methocarbamol

External links

• Bachmeyer C, Blum L, Fléchet M, Duriez P, Cabane J, Imbert J (1996). "[Severe contact dermatitis caused by mephenesin]". Ann Dermatol Venereol. 123 (3): 185–7. PMID 8761781. 
• Ono H, Nakamura T, Ito H, Oka J, Fukuda H (1987). "Rigidity in rats due to radio frequency decerebration and effects of chlorpromazine and mephenesin". Gen Pharmacol. 18 (1): 57–9. doi:10.1016/0306-3623(87)90170-4. PMID 3557053. 

References